about
Dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A) modulates serine/arginine-rich protein 55 (SRp55)-promoted Tau exon 10 inclusionThe pathobiology of splicingClinical Approach to Progressive Supranuclear PalsyTangles, Toxicity, and Tau Secretion in AD - New Approaches to a Vexing ProblemAlpha-synuclein and tau: teammates in neurodegeneration?Regulation of the alternative splicing of tau exon 10 by SC35 and Dyrk1ARNA and diseaseAmetantrone-based compounds as potential regulators of Tau pre-mRNA alternative splicing.Three repeat isoforms of tau inhibit assembly of four repeat tau filamentsAminopeptidases do not directly degrade tau protein.Neurofibrillary tangles and the deposition of a beta amyloid peptide with a novel N-terminal epitope in the brains of wild Tsushima leopard catsTranslating RNA sequencing into clinical diagnostics: opportunities and challenges.Mitochondrial complex 1 inhibition increases 4-repeat isoform tau by SRSF2 upregulation.Hypoxia alters expression of zebrafish microtubule-associated protein tau (mapta, maptb) gene transcripts.The role of DYRK1A in neurodegenerative diseases.Tau PET imaging: present and future directions.Splicing factor SC35 promotes tau expression through stabilization of its mRNA.Altered expression of Ano1 variants in human diabetic gastroparesisRegulation of alternative splicing of tau exon 10 by 9G8 and Dyrk1ATau splicing and the intricacies of dementia.Role of SFRS13A in low-density lipoprotein receptor splicingTau assembly: the dominant role of PHF6 (VQIVYK) in microtubule binding region repeat R3.SpliceDisease database: linking RNA splicing and diseaseThe Ambiguous Relationship of Oxidative Stress, Tau Hyperphosphorylation, and Autophagy Dysfunction in Alzheimer's Disease.RNA Structures as Mediators of Neurological Diseases and as Drug Targets.Using Human iPSC-Derived Neurons to Model TAU Aggregation.Exonic Splicing Mutations Are More Prevalent than Currently Estimated and Can Be Predicted by Using In Silico Tools.miR-132/212 deficiency impairs tau metabolism and promotes pathological aggregation in vivo.Transcriptomic changes in brain development.Alternative splicing of Drosophila Nmnat functions as a switch to enhance neuroprotection under stress.HIV-1-Tat Protein Inhibits SC35-mediated Tau Exon 10 Inclusion through Up-regulation of DYRK1A Kinase.The Microtubule-Associated Protein Tau and Its Relevance for Pancreatic Beta Cells.Gene Therapy Models of Alzheimer's Disease and Other Dementias.Toxic gain of function from mutant FUS protein is crucial to trigger cell autonomous motor neuron loss.iGEMS: an integrated model for identification of alternative exon usage events.PSF suppresses tau exon 10 inclusion by interacting with a stem-loop structure downstream of exon 10.Screening exons 16 and 17 of the amyloid precursor protein gene in sporadic early-onset Alzheimer's disease.Spliceosomes walk the line: splicing errors and their impact on cellular function.Mediators of tau phosphorylation in the pathogenesis of Alzheimer's disease.PERK activation mitigates tau pathology in vitro and in vivo.
P2860
Q24339549-F6EB967E-FB44-4A19-8C1A-9B60DD424D04Q24634680-3641456B-EACA-4D6C-898F-08B5CE87BBBAQ26772944-55ECE6C0-568C-4A67-951C-3030A7C94071Q27004724-F13EB2A2-9445-4E0C-B047-D328AB887E0AQ28250508-9010D3E9-B1C7-42CE-9B0B-8B04A73E1F96Q28592850-967904D8-E4AB-4BB0-9B92-56F0483468D9Q29615183-7F0F63EF-5823-42E2-8287-DC40282CEF55Q30867681-84A98E02-EAA0-426B-B9B7-BB072F80EA71Q33593147-66D9B174-90E5-4770-B320-1620AD97A9C6Q34335712-CF5CF818-2F03-4A9B-9669-B264839E1276Q34441477-4F98DAC3-A7FD-46E1-818F-41FD70C92311Q34519034-74B5DCEB-B972-48BE-8751-C5D208E9130EQ34526836-015221A5-74AA-4F6D-9534-6178A3B34AC0Q34537350-62B7A4B0-D944-4D05-8A97-4E33EFCBC3D8Q34642120-552AB30F-9D37-430E-9AF1-8C5DEF7BE1E5Q34680852-DE3AD1C1-72A6-4FCF-9DA5-BCEF9685DFBBQ34764464-D54B3B21-461D-4B7F-9CCA-ABF7610D9CEEQ34787213-F1EF360A-5B79-4075-812C-75C5025616E8Q34900413-376EC99A-E3C1-4ED5-B21D-CC086898235EQ35226142-F4AEECF4-FE16-4DC2-B5C9-AB76B43BEC66Q35251852-BDDF0D70-24B7-4475-AF54-7058102C0D5BQ35596910-D7A193D2-27FE-4EDB-8349-D2079139D5E6Q35630917-D49878EE-31BF-482B-87B1-5D9E7D189D6BQ35800000-4CB3E7FE-768F-4270-A50E-0F74591C0F1DQ35868044-E5B36FD0-0B07-4B29-B123-F3C8879AD869Q35882729-B869DE10-FDBE-4950-B2D9-CAC728BAEEB3Q35892850-D5E758E7-850B-4DE6-8086-7F18CD0FC317Q36251998-682C6A20-F9F7-4EFA-8873-CA20D47D26A7Q36325687-61BCE742-460E-4505-938D-2A605DBFEB1DQ36360700-7BA4BB57-0ED9-432E-BF7C-A5E642611C65Q36407266-D3C1A323-66CF-403B-AADC-86437E351127Q36448430-5E6B448F-C415-421F-ADC4-15679018A77EQ36524290-81B1448D-2DC0-414D-8258-19ABE08A839BQ36906420-6489EB2B-3041-49B8-AB82-8C0C69C65DACQ37021565-162CB13F-393C-4BA2-B4B0-84B442CB6C4EQ37483533-9BF2BC2B-563E-4282-A573-414FAF28F443Q37501882-65706F33-4FD0-4C92-B53E-78EB6AE642F0Q37549292-546FA79A-6D2D-4594-800C-8849EC0BAD2EQ37630546-0B215DC3-383F-4DFC-9E2F-969DF913B8DDQ37672742-83275E03-B5CE-4DB2-A5BB-A6B8A9087F91
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Tau exon 10 alternative splicing and tauopathies
@en
type
label
Tau exon 10 alternative splicing and tauopathies
@en
prefLabel
Tau exon 10 alternative splicing and tauopathies
@en
P2860
P356
P1476
Tau exon 10 alternative splicing and tauopathies
@en
P2093
P2860
P2888
P356
10.1186/1750-1326-3-8
P577
2008-07-10T00:00:00Z
P5875
P6179
1035102058